Published in Neurosurg Rev on June 16, 2007
Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA (2010) 2.00
Purinergic regulation of neutrophil chemotaxis. Cell Mol Life Sci (2008) 1.04
Resuscitation of traumatic hemorrhagic shock patients with hypertonic saline-without dextran-inhibits neutrophil and endothelial cell activation. Shock (2012) 0.98
Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study. Crit Care (2011) 0.95
Hypertonic saline alleviates cerebral edema by inhibiting microglia-derived TNF-α and IL-1β-induced Na-K-Cl Cotransporter up-regulation. J Neuroinflammation (2014) 0.88
Comparison of 7.2% hypertonic saline - 6% hydroxyethyl starch solution and 6% hydroxyethyl starch solution after the induction of anesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo) (2013) 0.85
Modern approaches to pediatric brain injury therapy. J Trauma (2009) 0.84
Efficacy and Safety of Continuous Micro-Pump Infusion of 3% Hypertonic Saline combined with Furosemide to Control Elevated Intracranial Pressure. Med Sci Monit (2015) 0.78
Hypertonic saline for brain relaxation and intracranial pressure in patients undergoing neurosurgical procedures: a meta-analysis of randomized controlled trials. PLoS One (2015) 0.78
Repeated dosing of 23.4% hypertonic saline for refractory intracranial hypertension. A case report. J Vasc Interv Neurol (2008) 0.75
Evaluation of the Maintained Effect of 3% Hypertonic Saline Solution in an Animal Model of Intracranial Hypertension. Med Sci Monit Basic Res (2016) 0.75
Hypertonic saline reduces vascular leakage in a mouse model of severe dengue. PLoS One (2013) 0.75
Hypertonic saline protects brain endothelial cells against hypoxia correlated to the levels of estimated glomerular filtration rate and interleukin-1β. Medicine (Baltimore) (2017) 0.75
Effect of hypertonic saline on hypotension following induction of general anesthesia: A randomized controlled trial. Adv Biomed Res (2014) 0.75
Efficacy of reductive ventricular osmotherapy in a swine model of traumatic brain injury. Neurosurgery (2012) 0.75
COBI (COntinuous hyperosmolar therapy for traumatic Brain-Injured patients) trial protocol: a multicentre randomised open-label trial with blinded adjudication of primary outcome. BMJ Open (2017) 0.75
A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med (1990) 9.42
The role of secondary brain injury in determining outcome from severe head injury. J Trauma (1993) 4.25
Presidental address. Neuropathological aspects of brain edema. J Neuropathol Exp Neurol (1967) 4.06
The release and uptake of excitatory amino acids. Trends Pharmacol Sci (1990) 3.80
Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA (2004) 3.54
Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med (1986) 3.44
Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci (1988) 3.13
The changing landscape of ischaemic brain injury mechanisms. Nature (1999) 2.91
Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial. J Neurosurg (1993) 2.37
A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer's solution versus hypertonic saline. Crit Care Med (1998) 2.17
Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci (1995) 2.13
Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med (2000) 1.98
Blood-brain barrier water permeability and brain osmolyte content during edema development. Acad Emerg Med (1997) 1.98
Brain edema. N Engl J Med (1975) 1.94
Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The U.S.A. Multicenter Trial. Ann Surg (1991) 1.75
Ischaemic brain damage in fatal non-missile head injuries. J Neurol Sci (1978) 1.74
Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain. Crit Care Med (1998) 1.72
Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med (1998) 1.70
Prolonged hypernatremia controls elevated intracranial pressure in head-injured pediatric patients. Crit Care Med (2000) 1.68
Guidelines for the management of severe head injury. Brain Trauma Foundation. Eur J Emerg Med (1996) 1.57
A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J Neurosurg (1998) 1.52
Hypertonic saline attenuates end-organ damage in an experimental model of acute pancreatitis. Br J Surg (2000) 1.51
Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study. J Neurosurg (1998) 1.49
Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol (1998) 1.36
Characterization of cerebral hemodynamic phases following severe head trauma: hypoperfusion, hyperemia, and vasospasm. J Neurosurg (1997) 1.36
Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest (1991) 1.33
Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38. J Clin Invest (1998) 1.31
3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Ann Surg (1987) 1.30
Fos production in retrogradely labelled neurons of the lamina terminalis following intravenous infusion of either hypertonic saline or angiotensin II. Neuroscience (1994) 1.26
Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock. J Trauma (1997) 1.26
Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol (1989) 1.25
Report of Joint Committee for Stroke Resources. IV. Brain edema in stroke. Stroke (1977) 1.22
Molecular mechanisms of developmental neuronal death. Annu Rev Neurosci (1993) 1.21
Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension. J Trauma (1997) 1.20
Dangers to infants caused by changes in osmolal concentration. Pediatrics (1967) 1.20
Hypertonic saline and dextran in normovolaemic and hypovolaemic healthy volunteers increases interstitial and intravascular fluid volumes. Acta Anaesthesiol Scand (1998) 1.20
Effect of high-dose dexamethasone on outcome from severe head injury. J Neurosurg (1986) 1.19
7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Arch Surg (1991) 1.16
Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke (1998) 1.14
Use of hypertonic saline/acetate infusion in treatment of cerebral edema in patients with head trauma: experience at a single center. J Trauma (1999) 1.13
Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression. J Trauma (1998) 1.07
Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. J Trauma (1993) 1.06
SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Res (2001) 1.06
Hypertonic saline lowers raised intracranial pressure in children after head trauma. J Neurosurg Anesthesiol (1992) 1.06
Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis. Am J Med (1985) 1.04
Quantitative measurement of bleeding following hypertonic saline therapy in 'uncontrolled' hemorrhagic shock. J Trauma (1989) 0.99
Hypertonicity prevents lipopolysaccharide-stimulated CD11b/CD18 expression in human neutrophils in vitro: role for p38 inhibition. J Trauma (1999) 0.99
Is hypertonic saline resuscitation safe in 'uncontrolled' hemorrhagic shock? J Trauma (1988) 0.96
Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery (1999) 0.96
Calcium movements in traumatic brain injury: the role of glutamate receptor-operated ion channels. J Cereb Blood Flow Metab (1996) 0.95
Subcortical white matter lesions in osmotic demyelination syndrome. AJNR Am J Neuroradiol (1995) 0.95
Plasma expanders. An update. Am J Surg (1988) 0.95
Intravenous fluid tonicity: effect on intracranial pressure, cerebral blood flow, and cerebral oxygen delivery in focal brain injury. J Neurosurg (1992) 0.95
Hemodynamically significant cerebral vasospasm and outcome after head injury: a prospective study. J Neurosurg (1997) 0.94
Hypertonic saline infusion: can it regulate human neutrophil function? Shock (2000) 0.94
Long-term observations of intracranial pressure after severe head injury. The phenomenon of secondary rise of intracranial pressure. Neurosurgery (1993) 0.93
Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Arch Surg (1990) 0.93
Head injury and hemorrhagic shock: studies of the blood brain barrier and intracranial pressure after resuscitation with normal saline solution, 3% saline solution, and dextran-40. Surgery (1988) 0.93
Hypertonic sodium resuscitation is associated with renal failure and death. Ann Surg (1995) 0.93
Regional cerebral blood volume after severe head injury in patients with regional cerebral ischemia. Neurosurgery (1998) 0.91
Hypertonic saline alters plasma clotting times and platelet aggregation. J Trauma (1991) 0.91
Use of a 7.5% NaCl/6% Dextran 70 solution in the resuscitation of injured patients in the emergency room. Prog Clin Biol Res (1989) 0.91
Effects of hypertonic saline on expression of human polymorphonuclear leukocyte adhesion molecules. J Leukoc Biol (2001) 0.91
Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir Suppl (1998) 0.90
A review of the efficacy and safety of 7.5% NaCl/6% dextran 70 in experimental animals and in humans. J Trauma (1994) 0.90
Acute hemodynamic effects of hypertonic (7.5%) saline infusion in patients with cardiogenic shock due to right ventricular infarction. Circ Shock (1992) 0.90
The use of hypertonic saline in the treatment of traumatic brain injury. J Trauma (2001) 0.90
Hypertonic saline activation of p38 MAPK primes the PMN respiratory burst. Shock (2001) 0.90
A comparison of hypertonic to isotonic fluid in the resuscitation of brain injury and hemorrhagic shock. J Surg Res (1991) 0.90
Hypertonic saline alteration of the PMN cytoskeleton: implications for signal transduction and the cytotoxic response. J Trauma (2001) 0.87
Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. Shock (2000) 0.87
Hypertonic/hyperoncotic saline attenuates microcirculatory disturbances after traumatic brain injury. J Trauma (1997) 0.87
Treatment of resistant intracranial hypertension with hypertonic saline. Report of two cases. J Neurosurg (1988) 0.87
Documented reversal of global ischemia immediately after removal of an acute subdural hematoma. Report of two cases. J Neurosurg (1994) 0.85
The effects of serum osmolarity on cerebrospinal fluid volume flow. Life Sci (1974) 0.85
Hypertonic saline attenuation of the neutrophil cytotoxic response is reversed upon restoration of normotonicity and reestablished by repeated hypertonic challenge. Surgery (2001) 0.85
Resuscitation from hemorrhagic shock. Alterations of the intracranial pressure after normal saline, 3% saline and dextran-40. Ann Surg (1986) 0.84
The role of organic osmolytes in the cerebral cell volume regulatory response to acute and chronic renal failure. J Am Soc Nephrol (1993) 0.84
Hypertonic saline treatment of acid aspiration-induced lung injury. J Surg Res (1996) 0.84
Hypertonic/hyperoncotic saline reliably reduces ICP in severely head-injured patients with intracranial hypertension. Acta Neurochir Suppl (1997) 0.84
Malignant cerebral edema in patients with hypertensive intracerebral hemorrhage associated with hypertonic saline infusion: a rebound phenomenon? J Neurosurg Anesthesiol (1998) 0.83
Avoidance of hypotension: conditio sine qua non of successful severe head-injury management. J Trauma (1997) 0.83
Comparative effects of crystalloid and small volume hypertonic hyperoncotic fluid resuscitation on hepatic microcirculation after hemorrhagic shock. Circ Shock (1993) 0.83
Combined hemorrhagic shock and head injury: effects of hypertonic saline (7.5%) resuscitation. J Trauma (1991) 0.83
Influence of hypertonic volume replacement on the microcirculation in cardiac surgery. Br J Anaesth (1991) 0.82
Resuscitation of hemorrhagic shock with hypertonic saline/dextran or lactated Ringer's supplemented with AICA riboside. Circ Shock (1993) 0.81
Sodium hyperosmolarity of intestinal lymph causes arteriolar vasodilation in part mediated by EDRF. Am J Physiol (1993) 0.81
Administration of hypertonic (3%) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg Anesthesiol (1999) 0.81
Human glial cell production of lipoxygenase-generated eicosanoids: a potential role in the pathophysiology of vascular changes following traumatic brain injury. J Trauma (1989) 0.81
Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances: II. Pediatr Nephrol (1992) 0.80
Prehospital care of the multiply injured patient: the challenge of figuring out what works. JAMA (2004) 0.80
Hypertonic saline activates lipid-primed human neutrophils for enhanced elastase release. J Trauma (1998) 0.80
Cerebrospinal fluid endothelin-1 and endothelin-3 levels in normal and neurosurgical patients: a clinical study and literature review. Surg Neurol (1991) 0.80
Continuous regional cerebral blood flow monitoring in acute craniocerebral trauma. Neurosurgery (1991) 0.80
Evidence for time-dependent glutamate-mediated glycolysis in head-injured patients: a microdialysis study. Acta Neurochir Suppl (1999) 0.80
Hypertonic saline induces prostacyclin production via extracellular signal-regulated kinase (ERK) activation. J Surg Res (1999) 0.80
Changes in brain organic osmolytes in experimental cerebral ischemia. J Neurol Sci (1998) 0.80
Atrial natriuretic peptide suppresses osmostimulated vasopressin release in young and elderly humans. Am J Physiol (1991) 0.80
Extracellular signal-related kinase 1/2 and p38 mitogen-activated protein kinase pathways serve opposite roles in neutrophil cytotoxicity. Arch Surg (1999) 0.79
Treatment of elevated intracranial pressure by infusions of 10% saline in severely head injured patients. Acta Neurochir Suppl (1998) 0.79
Particulate air pollution and acute health effects. Lancet (1995) 9.26
Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol (2001) 3.38
Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med (1996) 3.04
Nanotoxicology. Occup Environ Med (2004) 2.76
Free radical activity and pro-inflammatory effects of particulate air pollution (PM10) in vivo and in vitro. Thorax (1996) 2.58
The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol (1986) 2.44
Improved purification methods for calf-derived Cryptosporidium parvum oocysts using discontinuous sucrose and cesium chloride gradients. J Eukaryot Microbiol (1996) 2.16
Adverse health effects of PM10 particles: involvement of iron in generation of hydroxyl radical. Occup Environ Med (1996) 2.12
Inhalation of poorly soluble particles. II. Influence Of particle surface area on inflammation and clearance. Inhal Toxicol (2000) 1.99
Hypothesis: does COPD have an autoimmune component? Thorax (2003) 1.98
Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occup Environ Med (2000) 1.88
Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol Appl Pharmacol (2001) 1.78
Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles. Am J Physiol Lung Cell Mol Physiol (2003) 1.77
Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. Inhal Toxicol (1999) 1.76
The London Underground: dust and hazards to health. Occup Environ Med (2005) 1.73
Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med (2004) 1.71
Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD. Eur Respir J Suppl (2003) 1.60
Increased calcium influx in a monocytic cell line on exposure to ultrafine carbon black. Eur Respir J (2000) 1.51
An investigation of the role of glutathione in increased epithelial permeability induced by cigarette smoke in vivo and in vitro. Am J Respir Crit Care Med (1994) 1.42
Hypoplastic internal carotid artery mimicking a classic angiographic "string sign". Case report. J Neurosurg (1997) 1.38
When is hypospadias not hypospadias? Med J Aust (1996) 1.37
Activation of NF-kappaB by PM(10) occurs via an iron-mediated mechanism in the absence of IkappaB degradation. Toxicol Appl Pharmacol (2000) 1.36
Inhalation studies on the effects of tremolite and brucite dust in rats. Carcinogenesis (1985) 1.32
Relationship of internalized racism to abdominal obesity and blood pressure in Afro-Caribbean women. J Natl Med Assoc (1999) 1.29
The role of tumor necrosis factor in increased airspace epithelial permeability in acute lung inflammation. Am J Respir Cell Mol Biol (1995) 1.29
Variations in the carcinogenicity of mineral fibres. Ann Occup Hyg (1982) 1.29
Detection of surface free radical activity of respirable industrial fibres using supercoiled phi X174 RF1 plasmid DNA. Carcinogenesis (1995) 1.26
The role of oxidative stress in the prolonged inhibitory effect of ultrafine carbon black on epithelial cell function. Toxicol In Vitro (1998) 1.22
Oxidant-mediated lung epithelial cell tolerance: the role of intracellular glutathione and nuclear factor-kappaB. Biochem Pharmacol (2001) 1.18
Differences in the extent of inflammation caused by intratracheal exposure to three ultrafine metals: role of free radicals. J Toxicol Environ Health A (1998) 1.17
Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax (2007) 1.17
In vivo and in vitro proinflammatory effects of particulate air pollution (PM10). Environ Health Perspect (1997) 1.17
Degradation of connective tissue components by lung derived leucocytes in vitro: role of proteases and oxidants. Thorax (1988) 1.17
PM(10)-exposed macrophages stimulate a proinflammatory response in lung epithelial cells via TNF-alpha. Am J Physiol Lung Cell Mol Physiol (2002) 1.16
Mechanisms of cigarette smoke induced increased airspace permeability. Thorax (1996) 1.15
Management of cervical spine injuries in patients with ankylosing spondylitis. J Neurosurg (1990) 1.13
Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia. J Neurosurg (2000) 1.13
Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am J Physiol (1995) 1.12
Effect of cigarette smoke and its condensates on alveolar epithelial cell injury in vitro. Am J Physiol (1994) 1.12
Inflammatory effects of respirable quartz collected in workplaces versus standard DQ12 quartz: particle surface correlates. Toxicol Sci (2001) 1.11
Ultrafine particles and nitrogen oxides generated by gas and electric cooking. Occup Environ Med (2001) 1.10
Intravital fluorescence microscopy: impact of light-induced phototoxicity on adhesion of fluorescently labeled leukocytes. J Histochem Cytochem (1997) 1.10
Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways. Eur Respir J (2007) 1.10
Incidence and etiology of intracerebral hemorrhage following carotid endarterectomy. J Neurosurg (1986) 1.08
Aluminium lactate treatment of DQ12 quartz inhibits its ability to cause inflammation, chemokine expression, and nuclear factor-kappaB activation. Toxicol Appl Pharmacol (2001) 1.07
A dosimetric approach for relating the biological response of the lung to the accumulation of inhaled mineral dust. Br J Ind Med (1990) 1.07
How can ultrafine particles be responsible for increased mortality? Monaldi Arch Chest Dis (2000) 1.06
Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1. J Infect Dis (1991) 1.06
Inhibition of the transcription factors NF-kappa B and AP-1 underlies loss of cytokine gene expression in rat alveolar macrophages treated with a diffusible product from the spores of Aspergillus fumigatus. Am J Respir Cell Mol Biol (1996) 1.06
A novel model for human interstitial lung disease: hapten-driven lung fibrosis in rodents. J Pathol (1995) 1.05
Toxicity of fibers and particles. Report of the workshop held in Munich, Germany, 26-27 October 2000. Inhal Toxicol (2001) 1.01
In vitro toxicology of respirable Montserrat volcanic ash. Occup Environ Med (2000) 0.99
An improved macrophage spreading assay--a simple and effective measure of activation. Immunol Commun (1984) 0.99
Inflammatory responses in lungs of rats inhaling coalmine dust: enhanced proteolysis of fibronectin by bronchoalveolar leukocytes. Br J Ind Med (1989) 0.99
Bronchoalveolar leukocyte response in experimental silicosis: modulation by a soluble aluminum compound. Toxicol Appl Pharmacol (1989) 0.99
Seizures during the immediate postoperative period. Neurosurgery (1983) 0.99
Differential release of superoxide anions by macrophages treated with long and short fibre amosite asbestos is a consequence of differential affinity for opsonin. Occup Environ Med (1995) 0.98
The procoagulant potential of environmental particles (PM10). Occup Environ Med (2005) 0.98
Influence of fibre length, dissolution and biopersistence on the production of mesothelioma in the rat peritoneal cavity. Ann Occup Hyg (1999) 0.97
Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung. Thorax (1996) 0.97
Inhibition of the alveolar macrophage oxidative burst by a diffusible component from the surface of the spores of the fungus Aspergillus fumigatus. Thorax (1996) 0.96
Diagnosis and management of occipital condyle fractures. Neurosurgery (1994) 0.96
The biological effects of coarse and fine particulate matter. Occup Environ Med (2003) 0.96
Moyamoya disease in the midwestern United States. Neurosurg Focus (1998) 0.96
Characteristics of peritoneal macrophages induced by asbestos injection. Environ Res (1982) 0.95
Isolated central nervous system angiitis first presenting as spontaneous intracranial hemorrhage. Neurosurgery (1987) 0.95
Exacerbations of COPD: environmental mechanisms. Chest (2000) 0.94
Inhalation of poorly soluble particles. I. Differences in inflammatory response and clearance during exposure. Inhal Toxicol (2000) 0.94
Mechanistically identified suitable biomarkers of exposure, effect, and susceptibility for silicosis and coal-worker's pneumoconiosis: a comprehensive review. J Toxicol Environ Health B Crit Rev (2006) 0.93
Soluble transition metals in welding fumes cause inflammation via activation of NF-kappaB and AP-1. Toxicol Lett (2005) 0.92
In vitro assays for detecting carcinogenic mineral fibres: a comparison of two assays and the role of fibre size. Carcinogenesis (1986) 0.92
The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results. Inhal Toxicol (2010) 0.92
Hydrogen peroxide-induced epithelial injury: the protective role of intracellular nonprotein thiols (NPSH). Eur Respir J (1998) 0.91
Bilateral vagotomy or atropine pre-treatment reduces experimental diesel-soot induced lung inflammation. Toxicol Appl Pharmacol (2006) 0.91
Mathematical model of phagocytosis and inflammation after the inhalation of quartz at different concentrations. Scand J Work Environ Health (1995) 0.91
NiO and Co3O4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis. Eur Respir J (2011) 0.91
Regulation of lipopolysaccharide-mediated interleukin-1beta release by N-acetylcysteine in THP-1 cells. Eur Respir J (2000) 0.90
A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles. Inhal Toxicol (2008) 0.90
Organization of Genes Required for the Oxidation of Methanol to Formaldehyde in Three Type II Methylotrophs. Appl Environ Microbiol (1989) 0.90
Asbestos-activated peritoneal macrophages release a factor(s) which inhibits lymphocyte mitogenesis. Environ Res (1984) 0.89
Community hospitals and older people. Age Ageing (2001) 0.88
Energy expenditure and symptom severity in men with heart failure. Am J Cardiol (1996) 0.88
Acute respiratory distress syndrome and acute lung injury in patients with vertebral column fracture(s) and spinal cord injury: a nationwide inpatient sample study. Spinal Cord (2013) 0.88
The effect of oxidative stress on macrophages and lung epithelial cells: the role of phosphodiesterases 1 and 4. Toxicol Lett (2006) 0.88
Diesel exhaust particles override natural injury-limiting pathways in the lung. Am J Physiol Lung Cell Mol Physiol (2010) 0.88
Lipopolysaccharide-induced alveolar epithelial permeability: the role of nitric oxide. Am J Respir Crit Care Med (1998) 0.88
Cytoplasm-nuclear trafficking of CREB and CREB phosphorylation at Ser133 during therapy of chronic obstructive pulmonary disease. J Physiol Pharmacol (2007) 0.88
Effects of PM10 in human peripheral blood monocytes and J774 macrophages. Respir Res (2004) 0.88
Persistent depletion of I kappa B alpha and interleukin-8 expression in human pulmonary epithelial cells exposed to quartz particles. Toxicol Appl Pharmacol (2000) 0.87
Distal cervical carotid dissection after carotid endarterectomy: a complication of indwelling shunt? Neurosurgery (1986) 0.87
Increased release of hydrogen peroxide and superoxide anion from asbestos-primed macrophages. Effect of hydrogen peroxide on the functional activity of alpha 1-protease inhibitor. Inflammation (1985) 0.87
Inhalation and injection studies in rats using dust samples from chrysotile asbestos prepared by a wet dispersion process. Br J Exp Pathol (1986) 0.87
Alveolitis caused by exposure to coal mine dusts: production of interleukin-1 and immunomodulation by bronchoalveolar leukocytes. Environ Res (1990) 0.86
Free radical activity of industrial fibers: role of iron in oxidative stress and activation of transcription factors. Environ Health Perspect (1997) 0.86
Cytotoxic effect of asbestos on macrophages in different activation states. Environ Health Perspect (1983) 0.86
Method to perform IV injections on mice using the facial vein. J Neurosci Methods (2007) 0.86
The effects of intermittent high asbestos exposure (peak dose levels) on the lungs of rats. Br J Exp Pathol (1980) 0.86